{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T03:26:32Z","timestamp":1793589992626,"version":"4.5.0"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ejim.2026.107216","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:22:58Z","timestamp":1790050978000},"page":"107216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Quality Matters after acute myocardial infarction: making LDL-C risk visible, actionable, and accountable"],"prefix":"10.1016","volume":"153","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6943-278X","authenticated-orcid":false,"given":"Felice","family":"Gragnano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Leonardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2026.107216_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejim.2026.107061","article-title":"Reconsidering stepwise lipid-lowering titration and outpatient adherence dynamics after acute myocardial infarction","author":"Wang","year":"2026","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2026.107216_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejim.2026.106990","article-title":"Diagnostic and therapeutic inertia for LDL cholesterol management of consecutively verified patients with acute myocardial infarction","author":"Gragnano","year":"2026","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2026.107216_bib0003","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2026.17302","article-title":"LDL cholesterol lowering with evolocumab before percutaneous coronary intervention for acute myocardial infarction: the AMUNDSEN randomized clinical trial","author":"Montalescot","year":"2026","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2026.107216_bib0004","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1093\/eurheartj\/ehae576","article-title":"Intensive early and sustained lowering of non-high-density lipoprotein cholesterol after myocardial infarction and prognosis: the SWEDEHEART registry","volume":"45","author":"Schubert","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2026.107216_bib0005","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.123.010335","article-title":"Pragmatic trial of messaging to providers about treatment of hyperlipidemia (PROMPT-LIPID): a randomized clinical trial","volume":"17","author":"Shah","year":"2024","journal-title":"Circ Cardiovasc Qual Outcomes"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620526005212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620526005212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T02:53:48Z","timestamp":1793588028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620526005212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":5,"alternative-id":["S0953620526005212"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2026.107216","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality Matters after acute myocardial infarction: making LDL-C risk visible, actionable, and accountable","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2026.107216","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Federation of Internal Medicine. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107216"}}